 | Up a level |
Born, Alexander; Bocchi, Federica; Kuhn, Christian; Amstutz, Ursula; Baumgartner, Markus R; Sidler, Daniel (2023). Tacrolimus monitoring in hair samples of kidney transplant recipients. Frontiers in medicine, 10(1307505), p. 1307505. Frontiers 10.3389/fmed.2023.1307505
Tschudi, Letizia; Fischer, Sebastian Karl Maximilian; Perlov, Evgeniy; Baumgartner, Markus R; Soyka, Michael; Müller, Thomas Jörg; Seifritz, Erich; Mutschler, Jochen (2023). Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial? European addiction research, 29(5), pp. 305-312. Karger 10.1159/000531008
Kexel, Ann-Kathrin; Kluwe-Schiavon, Bruno; Baumgartner, Markus R; Engeli, Etna J E; Visentini, Monika; Kirschbaum, Clemens; Seifritz, Erich; Ditzen, Beate; Soravia, Leila M; Quednow, Boris B (2022). Cue-induced cocaine craving enhances psychosocial stress and vice versa in chronic cocaine users. Translational Psychiatry, 12(1), p. 443. Springer Nature 10.1038/s41398-022-02204-5
Zimmermann, Josua; Friedli, Nicole; Bavato, Francesco; Stämpfli, Philipp; Coray, Rebecca; Baumgartner, Markus R; Grandgirard, Denis; Leib, Stephen L; Opitz, Antje; Seifritz, Erich; Stock, Ann-Kathrin; Beste, Christian; Cole, David M; Quednow, Boris B (2022). White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels. NeuroImage: Clinical, 36, p. 103191. Elsevier 10.1016/j.nicl.2022.103191
Aue, Tatjana; Kexel, Ann-Kathrin; Kluwe-Schiavon, Bruno; Bührer, Stephanie; Baumgartner, Markus R; Soravia, Leila M; Quednow, Boris B (2022). In- and Out-Group Effects on Social Perception and Empathy in Cocaine Use Disorder. Frontiers in psychiatry, 13(879016), p. 879016. Frontiers 10.3389/fpsyt.2022.879016
Windhab, Laura G; Gastberger, Salome; Hulka, Lea M; Baumgartner, Markus R; Soyka, Michael; Müller, Thomas J; Seifritz, Erich; Mutschler, Jochen (2020). Dextromethorphan Abuse Among Opioid-Dependent Patients. Clinical neuropharmacology, 43(5), pp. 127-133. Wolters Kluwer Health 10.1097/WNF.0000000000000403
